Bluejay Diagnostics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Bluejay Diagnostics, Inc. (BJDX) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents4.302.2110.1119.050.91
Cash & Short-Term Investments4.302.2110.1119.050.91
Accounts Receivable0.010.000.000.000.00
Inventory0.000.000.000.000.08
Other Current Assets0.090.751.671.610.06
Total Current Assets4.903.2211.7920.661.06
Non-Current Assets
Property, Plant & Equipment (Net)1.721.621.700.330.46
Intangible Assets0.000.000.000.000.00
Other Non-Current Assets0.040.030.040.020.00
Total Non-Current Assets1.761.651.730.360.00
Total Assets6.664.8713.5221.021.52
Current Liabilities
Accounts Payable0.151.610.640.300.37
Short-Term Debt0.110.000.000.001.04
Current Portion of Long-Term Debt0.000.000.000.001.04
Accrued Liabilities0.551.110.830.340.13
Other Current Liabilities0.550.000.530.000.28
Total Current Liabilities0.811.771.640.641.85
Non-Current Liabilities
Long-Term Debt0.110.190.320.000.00
Other Non-Current Liabilities0.010.010.020.000.00
Total Non-Current Liabilities0.120.200.340.000.00
Total Liabilities0.931.971.980.641.85
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-34.67-26.95-17.00-7.69-4.21
Additional Paid-in Capital40.4029.8528.5428.070.00
Shares Outstanding0.140.000.000.000.00
Total Stockholders' Equity5.732.8911.5420.38-0.33
Total Liabilities & Equity6.664.8713.5221.020.00